Piscataway, NJ, United States of America

Leonid Minakhin


Average Co-Inventor Count = 12.6

ph-index = 3

Forward Citations = 50(Granted Patents)


Company Filing History:


Years Active: 2021-2022

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Inventive Journey of Leonid Minakhin

Introduction

Leonid Minakhin is a notable inventor located in Piscataway, NJ, who has made significant contributions to the field of molecular biology, particularly in the development of CRISPR technologies. With a total of three patents to his name, Minakhin has been pivotal in advancing methods for targeting nucleic acids, paving the way for innovative approaches in genetic research and therapeutics.

Latest Patents

Leonid Minakhin's latest patents focus on CRISPR enzymes and systems. The first invention outlines systems, methods, and compositions for targeting nucleic acids. Specifically, it introduces non-naturally occurring or engineered RNA-targeting systems, which include a novel RNA-targeting CRISPR effector protein paired with at least one targeting nucleic acid component such as a guide RNA. The second patent also emphasizes CRISPR technologies, particularly engineered DNA or RNA-targeting systems, comprising a novel CRISPR effector protein and various targeting components, aimed at enhancing precision in genetic manipulation.

Career Highlights

Leonid Minakhin has had a distinguished career, contributing to prestigious institutions such as the Broad Institute, Inc. and the Massachusetts Institute of Technology (MIT). His work at these esteemed organizations has facilitated groundbreaking research in genome editing, earning him recognition within the scientific community.

Collaborations

Throughout his career, Minakhin has collaborated with various esteemed colleagues, including Konstantin Severinov and Feng Zhang. These partnerships have fostered innovative ideas and shared expertise, further enriching the field of CRISPR technology.

Conclusion

Leonid Minakhin stands out as an inventive force in the realm of biotechnology, particularly in developing CRISPR systems that hold immense potential for future applications in genetics and medicine. With his continued dedication to innovation and research, Minakhin is sure to leave a lasting impact on the scientific community and beyond.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…